Involvement of Src in L-type Ca2+ channel depression induced by macrophage migration inhibitory factor in atrial myocytes

Journal of Molecular and Cellular Cardiology

Volumn 47, Issue 5, 2009, Pages 586-594

  Rao, Fang ^a   Deng, Chun Yu ^a   Wu, Shu Lin ^a   Xiao, Ding Zhang ^a   Yu, Xi Yong ^a   Kuang, Su Juan ^a   Lin, Qiu Xiong ^a   Shan, Zhi Xin ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Atrial fibrillation; Ca2+ channel; HL 1 cells; Macrophage migration inhibitory factor; Protein kinases

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 METHYLPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL L TYPE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GENISTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; PROTEIN SUBUNIT; PROTEIN TYROSINE KINASE;

ADULT; ANIMAL CELL; ARTICLE; CELL LINE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINUS RHYTHM; VOLTAGE CLAMP; WHOLE CELL;

ADULT; ANIMALS; ATRIAL FIBRILLATION; BLOTTING, WESTERN; CALCIUM CHANNELS, L-TYPE; CELL LINE; CELLS, CULTURED; ELECTROPHYSIOLOGY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MIDDLE AGED; MYOCYTES, CARDIAC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SRC-FAMILY KINASES;

EID: 70349734862     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2009.08.030     Document Type: Article

References (37)

1. Van Wagoner D.R. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J. Cardiovasc. Pharmacol. 52 (2008) 306-313
2. Abdelhadi R.H., Chung M.K., and Van Wagoner D.R. New hope for the prevention of recurrent atrial fibrillation. Eur. Heart J. 25 (2004) 1089-1090
3. Aviles R.J., Martin D.O., Apperson-Hansen C., Houghtaling P.L., Rautaharju P., Kronmal R.A., et al. Inflammation as a risk factor for atrial fibrillation. Circulation 108 (2003) 3006-3010
4. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am. Heart J. 148 (2004) 462-466
5. Hatzinikolaou-Kotsakou E., Tziakas D., Hotidis A., Stakos D., Floros D., Papanas N., et al. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am. J. Cardiol. 97 (2006) 659-661
6. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J. Am. Coll. Cardiol. 43 (2004) 2075-2082
7. Calandra T., Bernhagen J., Metz C.N., Spiegel L.A., Bacher M., Donnelly T., et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377 (1995) 68-71
8. Calandra T., Bernhagen J., Mitchell R.A., and Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179 (1994) 1895-1902
9. Burger-Kentischer A., Goebel H., Seiler R., Fraedrich G., Schaefer H.E., Dimmeler S., et al. Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105 (2002) 1561-1566
10. Willis M.S., Carlson D.L., Dimaio J.M., White M.D., White D.J., Adams G., et al. Macrophage migration inhibitory factor mediates late cardiac dysfunction after burn injury. Am. J. Physiol. Heart Circ. Physiol. 288 (2005) H795-804
11. Takahashi M., Nishihira J., Shimpo M., Mizue Y., Ueno S., Mano H., et al. Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes. Cardiovasc. Res. 52 (2001) 438-445
12. Kong Y.Z., Yu X., Tang J.J., Ouyang X., Huang X.R., Fingerle-Rowson G., et al. Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis 178 (2005) 207-215
13. Schmeisser A., Marquetant R., Illmer T., Graffy C., Garlichs C.D., Bockler D., et al. The expression of macrophage migration inhibitory factor 1alpha (MIF 1alpha) in human atherosclerotic plaques is induced by different proatherogenic stimuli and associated with plaque instability. Atherosclerosis 178 (2005) 83-94
14. Matsui Y., Okamoto H., Jia N., Akino M., Uede T., Kitabatake A., et al. Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. J. Mol. Cell. Cardiol. 37 (2004) 557-566
15. Miller E.J., Li J., Leng L., McDonald C., Atsumi T., Bucala R., et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature 451 (2008) 578-582
16. 2+ currents and human atrial fibrillation. Circ. Res. 85 (1999) 428-436
17. Yue L., Feng J., Gaspo R., Li G.R., Wang Z., and Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation. Circ. Res. 81 (1997) 512-525
18. 2+ channels in atrial fibrillation: wallflowers or a vanishing act. J. Mol. Cell. Cardiol. 35 (2003) 427-431
19. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001) 402-408
20. Ca,L in patients with chronic atrial fibrillation. Naunyn-Schmiedeberg's Arch. Pharmacol. 375 (2007) 383-392
21. 2+ channel activity by depressing the expression of channel protein in cortical neurons. J. Cell. Physiol. 206 (2006) 799-806
22. Tian M., Dong M.Q., Chiu S.W., Lau C.P., and Li G.R. Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents. Br. J. Pharmacol. 147 (2006) 289-297
23. Brundel B.J., Van Gelder I.C., Henning R.H., Tieleman R.G., Tuinenburg A.E., Wietses M., et al. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 103 (2001) 684-690
24. Brundel B.J., van Gelder I.C., Henning R.H., Tuinenburg A.E., Deelman L.E., Tieleman R.G., et al. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation. Cardiovasc. Res. 42 (1999) 443-454
25. 2+-channel, beta-adrenoreceptor, and 5-hydroxytryptamine type 4 receptor mRNAs in human atrial fibrillation. Basic Res. Cardiol. 96 (2001) 82-90
26. 2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110 (2004) 2651-2657
27. Li X.Q., Zhao M.G., Mei Q.B., Zhang Y.F., Guo W., Wang H.F., et al. Effects of tumor necrosis factor-alpha on calcium movement in rat ventricular myocytes. Acta Pharmacol. Sin. 24 (2003) 1224-1230
28. 2+ transients. FEBS Lett. 376 (1995) 24-30
29. + current. J. Neurophysiol. 95 2 (2006) 1042-1048
30. 2+ channel and their roles in activity regulation. Cardiovasc. Res. 69 (2006) 391-401
31. 2+ channel activity in human atrial myocytes. J. Mol. Cell. Cardiol. 37 (2004) 735-745
32. 2+ current cooperatively in human atrial myocytes. Am. J. Physiol. Heart Circ. Physiol. 278 (2000) H670-H676
33. 3 kinase, and NFkappaB. Blood 107 (2006) 2252-2261
34. Onodera S., Nishihira J., Iwabuchi K., Koyama Y., Yoshida K., Tanaka S., et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and-13 in rat osteoblasts. Relevance to intracellular signaling pathways. J. Biol. Chem. 277 (2002) 7865-7874
35. Erpel T., and Courtneidge S.A. Src family protein tyrosine kinases and cellular signal transduction pathways. Curr. Opin. Cell Biol. 7 (1995) 176-182
36. Dobrev D., and Nattel S. Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics. J. Cardiovasc. Pharmacol. 52 (2008) 293-299
37. Nattel S., Burstein B., and Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circulation: Arrhythm. Electrophysiol. 1 (2008) 62-73